{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Minneapolis",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "98097",
      "recalling_firm": "Medtronic Neuromodulation",
      "address_1": "7000 Central Ave Ne",
      "address_2": "",
      "postal_code": "55432-3568",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Worldwide - US Nationwide distribution.",
      "recall_number": "Z-1043-2026",
      "product_description": "A71200 Vanta\" Clinician Programmer Application (CP App) version  2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).",
      "product_quantity": "7123",
      "reason_for_recall": "Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.",
      "recall_initiation_date": "20251203",
      "center_classification_date": "20260109",
      "report_date": "20260121",
      "code_info": "version 2.0.2465 and 2.0.2683  UDI-DI (GTIN) 00763000520083  Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.",
      "more_code_info": ""
    }
  ]
}